InvestorsHub Logo
Followers 0
Posts 56
Boards Moderated 0
Alias Born 08/02/2021

Re: None

Wednesday, 03/23/2022 10:03:49 AM

Wednesday, March 23, 2022 10:03:49 AM

Post# of 44784
“A quick and effective way to improve the hematological profile of sick patients—resulting in faster recovery and decreased transfusions—would be a game-changer for the field, and we will continue to explore its clinical applications. The FDA’s recognition of PLX-R18’s potential to treat ARS is also significant. This treatment potentially carries great significance for current events in Ukraine and Europe, providing hope for treatment in the case of a nuclear event. We are proud of this product line, which might hold the key to promoting wellbeing, improving the standard of care, and possibly saving lives.”

Very important statement from $PSTI. Current events in Europe and today's results could make this treatment very relevant.